Abstract

This study explores the impact of diagnostic delays and presenting symptoms on the outcomes of pancreatic cancer patients. Utilizing a retrospective analysis of patient data, we examined how the timing of diagnosis and the nature of initial symptoms affect survival rates and treatment efficacy. Our findings reveal that longer diagnostic delays are associated with poorer prognosis, while certain presenting symptoms correlate with advanced disease stages at diagnosis. These insights underscore the importance of early detection and symptom recognition in improving patient outcomes. By highlighting the critical role of timely diagnosis and symptom assessment, this research aims to inform strategies for enhancing early intervention and patient management in pancreatic cancer care.